Skip to main content

Estrogen Gene Test, General Genetics Form Partnership

NEW YORK (GenomeWeb News) – The Estrogen Gene Test Co. announced on Tuesday a partnership with the Clinical Testing Laboratory to process EGT's saliva-based test for identifying polymorphisms in all of the key estrogen metabolism genes.

Clinical Testing Lab, a division of General Genetics, is CLIA-certified and provides genetic analysis services, including pharmacogenomics, genotyping, and other sequencing services.

Financial and other terms of the deal were not disclosed.

EGT's test called EstroGene was launched this week and investigates the key genes involved in estrogen metabolism.

EGT is an outgrowth of the work of the Hormonal Cancer Foundation and promotes estrogen metabolism genetic testing. General Genetics provides genetic testing services for the relationship, forensics, and clinical markets.

The Scan

US Supports Patent Waivers

NPR reports that the Biden Administration has announced its support for waiving intellectual property protections for SARS-CoV-2 vaccines.

Vaccines Versus Variants

Two studies find the Pfizer-BioNTech SARS-CoV-2 vaccine to be effective against viral variants, and Moderna reports on booster shots to combat variants.

CRISPR for What Ails You

The Wall Street Journal writes that CRISPR-based therapies could someday be used to treat common conditions like heart attacks.

Nature Papers Review Integration of Single-Cell Assay Data, Present Approach to Detect Rare Variants

In Nature this week: review of ways to integrate data from single-cell assays, and more.